
|Articles|December 5, 2022
Improving mAbs Impurity Clearance Through Use of Selective Additives
Author(s)Avantor
Finding more efficient ways to reduce processing times and improve downstream yields is a major bioprocessing industry challenge. In this study, two mAbs chromatography resins were examined. Both were used for a capture step, and additives were screened to reduce the nonspecific binding of impurities. The goal of the study was to optimize chromatography steps and thus increase the capacity and removal of impurities.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
FAQ: Pharmaceutical Outsourcing Trends and Innovations
2
FAQ: Everything to Know about 3D Printing in Pharma Manufacturing and Packaging
3
Lilly Launches UK Trial of Weight-Loss Drug as US Price Drops
4
Drug Solutions Podcast: Innovations in Orphan Drugs for Rare Diseases
5
